ŞAHİN, B. Et Al. 2022. The 5-HT7 receptor antagonist SB-269970 alleviates seizure activity and downregulates hippocampal c-Fos expression in pentylenetetrazole-induced kindled rats. NEUROLOGICAL RESEARCH , vol.44, no.9 , 786-796.

ŞAHİN, B., ÖZDEMİR, E., Gumus, E., ERGÜL, M., & TAŞKIRAN, A. Ş., (2022). The 5-HT7 receptor antagonist SB-269970 alleviates seizure activity and downregulates hippocampal c-Fos expression in pentylenetetrazole-induced kindled rats. NEUROLOGICAL RESEARCH , vol.44, no.9, 786-796.

ŞAHİN, BİLAL Et Al. "The 5-HT7 receptor antagonist SB-269970 alleviates seizure activity and downregulates hippocampal c-Fos expression in pentylenetetrazole-induced kindled rats," NEUROLOGICAL RESEARCH , vol.44, no.9, 786-796, 2022

ŞAHİN, BİLAL Et Al. "The 5-HT7 receptor antagonist SB-269970 alleviates seizure activity and downregulates hippocampal c-Fos expression in pentylenetetrazole-induced kindled rats." NEUROLOGICAL RESEARCH , vol.44, no.9, pp.786-796, 2022

ŞAHİN, B. Et Al. (2022) . "The 5-HT7 receptor antagonist SB-269970 alleviates seizure activity and downregulates hippocampal c-Fos expression in pentylenetetrazole-induced kindled rats." NEUROLOGICAL RESEARCH , vol.44, no.9, pp.786-796.

@article{article, author={BİLAL ŞAHİN Et Al. }, title={The 5-HT7 receptor antagonist SB-269970 alleviates seizure activity and downregulates hippocampal c-Fos expression in pentylenetetrazole-induced kindled rats}, journal={NEUROLOGICAL RESEARCH}, year=2022, pages={786-796} }